2.39

2.14% 0.05

Tuhura Biosciences Inc (HURA)

Overview News Price History Discussions Forecast

Tuhura Biosciences Inc stock is traded at $2.39, with a volume of 510.62K. It is up +2.14% in the last 24 hours and up +14.90% over the past month. TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.

Previous Close:

$2.34

Open:

$2.33

24h Volume:

510.62K

Relative Volume:

0.60

Market Cap:

$152.20M

Revenue:

Net Income/Loss:

$-30.92M

P/E Ratio:

-3.9642

EPS:

-0.6029

Net Cash Flow:

$-27.39M

1W Performance:

-2.05%

1M Performance:

+14.90%

6M Performance:

+217.10%

1Y Performance:

-5.16%

1-Day Range:

$2.32

$2.48

1-Week Range:

$2.15

$2.50

52-Week Range:

$0.41

$3.90

Tuhura Biosciences Inc Stock (HURA) Company Profile

Name

Tuhura Biosciences Inc

Sector

Healthcare (1096)

Industry

Biotechnology (616)

Phone

813-875-6600

Address

10500 UNIVERSITY CENTER DR., TAMPA

Employee

Twitter

Next Earnings Date

2024-11-11

Latest SEC Filings

HURA's Discussions on Twitter

Compare HURA vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HURA Tuhura Biosciences Inc	2.39	152.20M	0	-30.92M	-27.39M	-0.6029
VRTX Vertex Pharmaceuticals Inc	485.39	123.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	664.52	69.67B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.62	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	298.76	39.89B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	186.88	39.73B	742.00K	-1.37B	-1.07B	-7.0731

Tuhura Biosciences Inc Stock (HURA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-27-26	Initiated	Citizens	Mkt Outperform
Mar-03-25	Initiated	H.C. Wainwright	Buy
Dec-19-24	Initiated	Rodman & Renshaw	Buy
Nov-05-24	Initiated	Maxim Group	Buy

Tuhura Biosciences Inc Stock (HURA) Latest News

Jul 09, 2026

Form DEF 14A TuHURA Biosciences For: 9 July By Investing.com - Investing.com Nigeria

Jul 09, 2026

Jul 07, 2026

TuHURA Biosciences, Inc. (NASDAQ: HURA) Files 8-K Report Detailing Company Information and Compliance Updates – Minichart - Minichart

Jul 07, 2026

TuHURA Biosciences Expands Use of Revolving Credit Facility - TipRanks

Jul 07, 2026

Jul 04, 2026

TuHURA Biosciences names Amanda Garofalo as clinical operations SVP - Investing.com

Jul 04, 2026

Jun 29, 2026

TuHURA Biosciences, Inc.(NasdaqCM: HURA) dropped from Russell 2000 Dynamic Index - marketscreener.com

Jun 29, 2026

TuHURA Biosciences, Inc.(NasdaqCM: HURA) dropped from Russell 3000E Index - marketscreener.com

Jun 29, 2026

TuHURA Biosciences, Inc.(NasdaqCM:HURA) dropped from Russell Small Cap Completeness Index - marketscreener.com

Jun 29, 2026

TuHURA Biosciences, Inc.(NasdaqCM: HURA) dropped from Russell 2500 Index - marketscreener.com

Jun 29, 2026

Enterprise value to EBIT forward of TuHURA Biosciences, Inc. – FWB:PL3 - TradingView

Jun 29, 2026

TuHURA Biosciences, Inc.(NasdaqCM: HURA) dropped from Russell 3000 Index - marketscreener.com

Jun 29, 2026

TuHURA Biosciences, Inc.(NasdaqCM: HURA) dropped from Russell 2000 Index - marketscreener.com

Jun 29, 2026

TuHURA Biosciences, Inc.(NasdaqCM:HURA) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com

Jun 29, 2026

Jun 28, 2026

TuHURA Biosciences, Inc.(NasdaqCM:HURA) dropped from Russell 3000 Growth Benchmark - marketscreener.com

Jun 28, 2026

TuHURA Biosciences, Inc.(NasdaqCM:HURA) dropped from Russell 2500 Growth Benchmark - marketscreener.com

Jun 28, 2026

Jun 27, 2026

Enterprise value to EBITDA forward of TuHURA Biosciences, Inc. – NASDAQ:HURA - TradingView

Jun 27, 2026

Enterprise value to revenue forward of TuHURA Biosciences, Inc. – NASDAQ:HURA - TradingView

Jun 27, 2026

Net income before discontinued operations of TuHURA Biosciences, Inc. – DUS:PL3 - TradingView

Jun 27, 2026

TuHURA Biosciences, Inc. Balance Sheet – DUS:PL3 - TradingView

Jun 27, 2026

Form PRE 14A TuHURA Biosciences For: 26 June By Investing.com - Investing.com Nigeria

Jun 27, 2026

Jun 26, 2026

TuHURA Biosciences (HURA) virtual annual meeting Aug 18; shareholders to vote on 1.88M-share issuance - Stock Titan

Jun 26, 2026

TuHURA Biosciences, Inc. Actuals & Estimates (NASDAQ:HURA) - TradingView

Jun 26, 2026

Jun 25, 2026

TuHURA Biosciences, Inc. Actuals & Estimates (MUN:PL3) - TradingView

Jun 25, 2026

HURA Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

PL3 Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

TuHURA Biosciences (HURA) Short Interest & Short Float | Updated Jun 2026 - MarketBeat

Jun 25, 2026

Jun 24, 2026

TuHURA Biosciences (HURA) Dips 4.55% as Shares Approach Key Support LevelLate Stage Breakouts - dars.gov.et

Jun 24, 2026

Jun 22, 2026